vTv Therapeutics, which is developing a drug to treat diabetes, saw its stock rise 113% Wednesday after it announced a $51 million infusion from a private sale of stock to well-known health care investors.
Read More
Three more public companies have updated their earnings. Here’s the latest from Fathom Holdings, Asensus Surgical and VTv Therapeutics.
Read More
High Point’s vTv Therapeutics will soon have a new chief executive, as the company could be preparing to raise more capital.
Read More
The publicly-traded, High Point-based vTv Therapeutics has entered into agreements that include bringing in $10 million in cash.
Read More
Headlines from across North Carolina include a new CEO at biotech VtV, a deal by AQuity in Cary, nCino lands a,new customer, an update from Verona, Mack Trucks’ electric truck, and more …
Read More
vTv Therapeutics is slashing 65% of its workforce as part of a strategy to focus on upcoming late stage clinical trials of its drug targeting Type 1 Diabetes.
Read More
The Deloitte 2021 North America Technology Fast 500 includes seven North Carolina companies, with Nufabrx ranking 8th. Pendo, Sift Media, FM:Systems, vTV Therapeutics, Precision BioSciences, and MedShift also appear ranked.
Read More
It’s earnings season, and companies across North Carolina are reporting financial results for the most recent quarter. Here’s a wrapup:
Read More
The High Point-based vTv Therapeutics Inc. has received a designation as a breakthrough therapy by the U.S. FDA for its TTP399 oral supplement that treats type 1 diabetes and psoriasis.
Read More
